Hopes a new tool will be able to help the fight against vaping
Summary
New Zealand's MedSafe has approved a novel oral spray designed as a nicotine replacement therapy specifically for vaping cessation. Letitia Harding, Chief Executive of the Asthma and Respiratory Foundation, stated the spray will be widely accessible in dairies, vape stores, and pharmacies. This development aims to assist a significant number of young vapers, as statistics indicate high rates of vaping among high school students, with approximately 20% of year 12 students and 26% of year 13 students reporting recent vaping activity.
(Source:Nzcity Personal)